Having been forced to withdraw his statement questioning the efficacy of allopathy medicines, yoga guru Ramdev on Monday asked the Indian Medical Association if allopathy offered permanent relief for ailments such as hypertension and diabetes.
In an ‘open letter’ posted on his Twitter handle, Ramdev posed 25 questions to IMA, which had objected to his video clip running down allopathy treatment for COVID-19.
He asked if allopathy offered permanent relief from hypertension and type-1 and 2 diabetes.
“Does the pharma industry have permanent treatment for thyroid, arthritis, colitis and asthma?” he asked.
Ramdev went on to ask if allopathy had medicines for fatty liver and liver cirrhosis. “Like you found a cure for TB and chicken pox, look for treatments for liver ailments. After all, allopathy is now 200 years old.”
He further asked what non-surgical cure does the pharma industry have for heart blockage. “What treatment is there for cholesterol.”
“Does the pharma industry have treatment for migraine?”, or treatment for constipation and bloating amnesia without any side effects, he said.
The yoga guru went on to list modern day ailments such as Parkinson’s disease and asked if allopathy had any painless cure to treat infertility as well as to reverse ageing and increase hemoglobin.
“Doctors should not fall ill at all if allopathy is all powerful and ‘sarvagun sampanna’ (having all good qualities),” he remarked.
मैं इंडियन मेडिकल एसोसिएशन व फार्मा कंपनियों से विनम्रता के साथ सीधे 25 सवाल पूछता हूँ- pic.twitter.com/ATVKlDc9tl
— स्वामी रामदेव (@yogrishiramdev) May 24, 2021
On Sunday, Ramdev was forced to withdraw a statement made in a viral video clip in which he is heard saying that “lakhs have died from taking allopathic medicines for COVID-19.”
He is also heard questioning some of the medicines being used to treat Covid-19.
The remarks were met with vociferous protests from the doctors’ association, following which Union Health Minister Harsh Vardhan asked him to withdraw the “extremely unfortunate” statement.
-PTI
Discussion about this post